Authors


Erin O'Brien

Latest:

NDA for Investigational Schizophrenia Treatment Submitted to FDA

The NDA was submitted for investigational muscarinic antipsychotic, KarXT (xanomeline-trospium), which functions as a dual M1/M4 muscarinic acetylcholine receptor agonist within the central nervous system.


Amanda Clouser, PharmD

Latest:

Review: Harmful Excipients for Pediatric Patients

Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.


Megan Wright, CPhT-Adv

Latest:

Pharmacy Technicians Provide Patient Assistance With Oral Oncolytics

Pharmacy technicians can provide a great amount of value for patients navigating the financial toxicity of cancer treatment.


Julia Bonavitacola

Latest:

Approach to Breast Reconstruction Varies Among Women Based on Attributional Values

Understanding which factors are most important to women undergoing breast reconstruction surgery may help personalize preoperative counseling and improve rates of satisfaction associated with the operation.


Catherine Y. Spong, MD

Latest:

Protecting Our Most Vulnerable Through Vaccination

For more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.



Olivia G. Funk, PharmD Candidate

Latest:

Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common Cold

Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.


Shams Alrubaie, PharmD Candidate

Latest:

New Advances in Breast Cancer Therapy

Breast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.


David Hutton

Latest:

Two Eye Diseases Could Contribute to Common Blinding Eye Condition

The study could lead to early diagnosis and treatment of age-related macular degeneration.


Lauren Jonas, MD

Latest:

Preventing Severe Respiratory Infections in Children

A refresher on best interventions for common respiratory disorders in children.


Ollin Sykes, CPA, CITP

Latest:

Focus on DIR Fees: 3 Ways to Manage Them

When investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.


Bonnie Bond, CPA

Latest:

Maximizing Adherence Packaging for Patient Health and Pharmacy Growth

Is adherence packaging technology a big investment for a community or independent pharmacy?


Carrie W. Nemerovski, PharmD

Latest:

OTC Drug Interaction Considerations in the Cough and Cold Aisle

OTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.


Kris Rhea

Latest:

Four Simple Steps to Turn a Pharmacy’s Front End Into a Profit Magnet

Filling prescriptions is no longer a sufficient source of revenue for community pharmacy.


Ariana Pelosci

Latest:

Efficacy Outcomes of Some Cancer Biosimilars Indistinguishable Vs Reference Product

Findings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.


Thomas W. Laudone, PharmD, BCPPS

Latest:

Case Study: Treating Infants for Cannabis Exposure

As more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.


Rachel H. Alinsky, MD, MPH

Latest:

Cannabinoid Hyperemesis Syndrome: Diagnosis and Management

A deep dive for pharmacists into this frequently debilitating disorder


Katie Hobbins

Latest:

Creating A Successful Social Media Presence

Social media is a great way to gain exposure, but there are many dos-and-don’ts to understand when signing up for a social platform.


Matthew Fowler

Latest:

COVID-19 Vaccines: T Cell, Antibody Responses Demonstrated in CLL

Patients with chronic lymphocytic leukemia experienced functional T cell and antibody responses after receiving a vaccine for COVID-19.


Oriana Lerner

Latest:

Breaking Down the Numbers for Isotretinoin AEs

Recent meta-analysis takes a look at possible adverse effects of the acne medicine, their frequency and severity.


Maggie L. Shaw

Latest:

Biosimilars Are Bringing Affordability and Accessibility

Lower costs, increased availability, and assistance programs are “game changers” for patients.


Robert Calandra

Latest:

Why Is There Such A Large Disparity In Who Meets Critera For Hepatitis B Treatment?

Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.


Madeleine Depinho, BS, PharmD Candidate 2022

Latest:

New Drug Review: Atogepant FDA-Approved for Migraine Treatment

On September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.


Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES

Latest:

Basal Insulin Therapies for Diabetes Management

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and Thomas C. Blevins, MD, ECNU, FACE, FNLA, review FDA-approved basal insulins for the management of diabetes.


Egla Hasimllari, PharmD

Latest:

Vivjoa Approved for Recurrent Vulvovaginal Candidiasis

Oteseconazole is a treatment option for those living with a previously unmet medical need.


Tom Knight, MBA, MS

Latest:

Challenges of Drug Diversion in Health Care Settings Amid High Staff Turnover, Budget Cuts

With the risk of diversion potentially greater than it was before the pandemic, these data should be viewed as a warning sign.


Tracy D Mahvan, RPh, PharmD, MBA, BCGP

Latest:

OTC Considerations for COVID-19

Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves


Kathy Blanchard

Latest:

Focus on DIR Fees: 3 Ways to Manage Them

When investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.


Bridget Hanna, CPhT

Latest:

Do’s And Don’ts: Social Media Tips for Pharmacists

Social media marketing is a powerful tool that pharmacists can use.


Sandhya Vijapurapu, PharmD Candidate

Latest:

Digital Health Tools in Diabetes

Technology and mobile health apps can be valuable tools in diabetes management.

© 2024 MJH Life Sciences

All rights reserved.